Delayed cytokine expression in rat brain following experimental contusion

Journal of Neurosurgery

Volumn 86, Issue 3, 1997, Pages 493-504

  Holmin, Staffan ^b   Schalling, Martin ^b   Höjeberg, Bo ^b   Nordqvist, Ann Christin Sandberg ^b   Skeftruna, Ann Katrin ^b   Mathiesen, Tiit ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

brain injury; inflammation; interferon ; interleukin 1 ; interleukin 6; rat; tumor necrosis factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CONTUSION; BRAIN EDEMA; CONTROLLED STUDY; CORPUS CALLOSUM; ENCEPHALITIS; FEMALE; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031017661     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1997.86.3.0493     Document Type: Article

References (80)

1. Akira S, Hirano T, Taga T, et al: Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J 4:2860-2867, 1990
2. Andersson PB, Perry VH, Gordon S: The acute inflammatory response to lipopolysaccharide in CNS parenchyma differs from that in other body tissues. Neuroscience 48:169-186, 1992
3. Andersson PB, Perry VH, Gordon S: The CNS acute inflammatory response to excitotoxic neuronal cell death. Immunol Lett 30:177-182, 1991
4. Blight AR: Delayed demyelination and macrophage invasion: a candidate for secondary cell damage in spinal cord injury. Cent Nerv Syst Trauma 2:299-315, 1985
5. Blight AR: Macrophages and inflammatory damage in spinal cord injury. J Neurotrauma 9 (Suppl 1):83-91, 1992
6. Bruce AJ, Boling W, Kindy MS, et al: Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors. Nature Med 2:788-794, 1996
7. Bullock R, Statham P, Patterson J, et al: The time course of vasogenic oedema after focal human head injury - evidence from SPECT mapping of blood brain barrier defects. Acta Neurochir Suppl 51:286-288, 1990
8. Bullock R, Statham P, Patterson J, et al: Tomographic mapping of CBF, CBV and blood brain barrier changes after focal head injury, using SPECT-mechanisms for late deterioration, in Hoff J, Betz AL (eds): Intracranial Pressure VII. Berlin: Springer-Verlag, 1989, pp 637-639
9. Chavanet P, Bonnotte B, Guiguet M, et al: High concentrations of intrathecal interleukin-6 in human bacterial and nonbacterial meningitis. J Infect Dis 166:428-431, 1992
10. Chung IY, Benveniste EN: Tumor necrosis factor-α production by astrocytes. Induction by lipopolysaccharide, IFN-γ, and IL-1β. J Immunol 144:2999-3007, 1990
11. Claudio L, Martiney JA, Brosnan CF: Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1β or tumor necrosis factor-α. Lab Invest 70:850-861, 1994
12. Cohadon F: Brain protection. Adv Tech Stand Neurosurg 21: 77-152, 1994
13. Collart MA, Belin D, Vassalli JD, et al: γ Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp Med 164:2113-2118, 1986
14. Cuzner ML, Hayes GM, Newcombe J, et al: The nature of inflammatory components during demyelination in multiple sclerosis. J Neuroimmunol 20:203-209, 1988
15. de Vries HE, Blom-Roosemalen MCM, Van Oosten M, et al: The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol 64:37-43, 1996
16. Du Plessis JJ: High-dose dexamethasone therapy in head injury: a patient group that may benefit from therapy. Br J Neurosurg 6:145-147, 1992
17. Dusart I, Schwab ME: Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 6:712-724, 1994
18. Fan L, Perlman KP, Young PR, et al: Experimental brain injury induces expression of tumor necrosis factor-α mRNA. J Neurotrauma 11:108, 1994 (Abstract)
19. Fan L, Young PR, Barone FC, et al: Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res Mol Brain Res 30:125-130, 1995
20. Feeney DM, Boyeson MG, Linn RT, et al: Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 211:67-77, 1981
21. Feuerstein GZ, Liu T, Barone FC: Cytokines, inflammation, and brain injury: role of tumor necrosis factor-alpha. Cerebrovasc Brain Metab Rev 6:341-360, 1994
22. Frei K, Piani D, Pfister HW, et al: Immune-mediated injury in bacterial meningitis. Int Rev Exp Pathol 34:183-192, 1993
23. Giulian D, Baker TJ, Shih LCN, et al: Interleukin I of the central nervous system is produced by ameboid microglia. J Exp Med 164:594-604, 1986
24. Giulian D, Chen J, Ingeman JE, et al: The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 9:4416-4429, 1989
25. Giulian D, Lachman LB: Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 228:497-499, 1985
26. Giulian D, Robertson C: Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann Neurol 27: 33-12, 1990
27. Giulian D, Woodward J, Young DG, et al: Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 8:2485-2490, 1988
28. Gordon CR, Merchant RS, Marmarou A, et al: Effect of murine recombinant interleukin-1 on brain oedema in the rat. Acta Neurochir Suppl 51:268-270, 1990
29. Goss JR, Styren SD, Miller PD, et al: Hypothermia attenuates the normal increase in interleukin 1 beta RNA and nerve growth factor following traumatic brain injury in the rat. J Neurotrauma 12:159-167, 1995
30. Grady MS, McLaughlin MR, Christman CW, et al: The use of antibodies targeted against the neurofilament subunits for the detection of diffuse axonal injury in humans. J Neuropathol Exp Neurol 52:143-152, 1993
31. Hirschberg DL, Yoles E, Belkin M, et al: Inflammation after axonal injury has conflicting consequences for recovery of function: rescue of spared axons is impaired but regeneration is supported. J Neuroimmunol 50:9-16, 1994
32. Holmin S, Mathiesen T: Biphasic edema development after experimental brain contusion in rat. Neurosci Lett 194:97-100, 1995
33. Holmin S, Mathiesen T: Dexamethasone and colchicine reduce inflammation and delayed edema following experimental brain contusion. Acta Neurochir 138:418-424, 1996
34. Holmin S, Mathiesen T, Shetye J, et al: Intracerebral inflammatory response to experimental brain contusion. Acta Neurochir 132:110-119, 1995
35. Kishimoto T: The biology of interleukin-6. Blood 74:1-10, 1989
36. Lassmann H, Zimprich F, Rössler K, et al: Inflammation in the nervous system. Basic mechanisms and immunological concepts. Rev Neurol 147:763-781, 1991
37. Liu T, Clark RK, McDonnell PC, et al: Tumor necrosis factor-α expression in ischemic neurons. Stroke 25:1481-1488, 1994
38. Lynch DR, Dawson TM: Secondary mechanisms in neuronal trauma. Curr Opin Neurol 7:507-516, 1994
39. Male D, Pryce G, Rahman J: Comparison of the immunological properties of rat cerebral and aortic endothelium. J Neuroimmunol 30:161-168, 1990
40. Mathiesen T, Kakarieka A, Edner G: Traumatic intracerebral lesions without extracerebral haematoma in 218 patients. Acta Neurochir 137:155-163, 1995
41. May MJ, Ager A: ICAM-1-independent lymphocyte transmigration across high endothelium: differential up-regulation by interferon γ, tumor necrosis factor-α and interleukin 1 β. Eur J Immunol 22:219-226, 1992
42. McClain C, Cohen D, Phillips R, et al: Increased plasma and ventricular fluid interleukin-6 levels in patients with head injury. J Lab Clin Med 118:225-231, 1991
43. McClain CJ, Cohen D, Ott L, et al: Ventricular fluid interleukin-1 activity in patients with head injury. J Lab Clin Med 110: 48-54, 1987
44. McIntosh TK: Neurochemical sequelae of traumatic brain injury: therapeutic implications. Cerebrovasc Brain Metab Rev 6:109-162, 1994
45. McIntosh TK: Novel pharmacologic therapies in the treatment of experimental traumatic brain injury: a review. J Neurotrauma 10:215-261, 1993
46. McLaurin RL, Helmer F: The syndrome of temporal-lobe contusion. J Neurosurg 23:296-304, 1965
47. Megyeri P, Ábrahám CS, Temesvári P, et al: Recombinant human tumor necrosis factor a constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci Lett 148:137-140, 1992
48. Merrill JE: Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 14:1-10, 1992
49. Nieto-Sampedro M, Berman MA: Interleukin-1-like activity in rat brain: sources, targets, and effect of injury. J Neurosci Res 17:214-219, 1987
50. Olsson T: Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 144:245-268, 1995
51. Olsson T, Maehlen J, Love A, et al: Induction of class I and class II transplantation antigens in rat brain during fatal and non-fatal measles virus infection. J Neuroimmunol 16: 215-224, 1987
52. Ott L, McClain CJ, Gillespie M, et al: Cytokines and metabolic dysfunction after severe head injury. J Neurotrauma 11: 447-472, 1994
53. Povlishock JT, Kontos HA: The role of oxygen radicals in the pathobiology of traumatic brain injury. Hum Cell 5:345-353, 1992
54. Quagliarello VJ, Wispelwey B, Long WJ, Jr., et al: Recombinant human interleukin-1 induces meningitis and blood-brain barrier injury in the rat. Characterization and comparison with tumor necrosis factor. J Clin Invest 87:1360-1366, 1991
55. Raine CS: Multiple sclerosis: immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol 53:328-337, 1994
56. Raziuddin S, Mir NA, el-Awad MEH, et al: γδ T lymphocytes and proinflammatory cytokines in bacterial meningitis. J Allerg Clin Immunol 93:793-798, 1994
57. Relton JK, Rothwell NJ: Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 29:243-246, 1992
58. Robbins DS, Shirazi Y, Drysdale BE, et al: Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J Immunol 139:2593-2597, 1987
59. Ross SA, Halliday MI, Campbell GC, et al: The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg 8:419-425, 1994
60. Rothwell NJ, Relton JK: Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci Biobehav Rev 17: 217-227, 1993
61. Rothwell NJ, Relton JK: Involvement of interleukin-1 and lipocortin-1 in ischaemic brain damage. Cerebrovasc Brain Metab Rev 5:178-198, 1993
62. Rott O, Fleischer B, Cash E: Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 24: 1434-1440, 1994
63. Schalling M: In situ hybridization and immunohistochemical methods in study of regulatory molecules, in Conn PM (ed): Methods in Neurosciences. Vol 9: Gene Expression in Neural Tissues. San Diego: Academic Press, 1992, pp 231-255
64. Schalling M, Dagerlind Å, Brené S, et al: Coexistence and gene expression of phenylethanolamine N-methyltransferase, tyrosine hydroxylase, and neuropeptide tyrosine in the rat and bovine adrenal gland: effects of reserpine. Proc Natl Acad Sci USA 85:8306-8310, 1988
65. 2: cytokines with identical immunosuppressive effects and a potential role in the regulation of autoimmune T cell function. J Neuroimmunol 24:249-258, 1989
66. Seki T, Joh K, Oh-ishi T: Augmented production of interleukin-8 in cerebrospinal fluid in bacterial meningitis. Immunology 80:333-335, 1993
67. Selmaj KW, Raine CS: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23: 339-346, 1988
68. Sethna MP, Lampson LA: Immune modulation within the brain: recruitment of inflammatory cells and increased major histocompatibility antigen expression following intracerebral injection of interferon-γ. J Neuroimmunol 34:121-132, 1991
69. Shohami E, Novikov M, Bass R, et al: Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J Cereb Blood Flow Metab 14:615-619, 1994
70. Statham PF, Johnston RA, Macpherson P: Delayed deterioration in patients with traumatic frontal contusions. J Neurol Neurosurg Psychiatry 52:351-354, 1989
71. Stein SC, Spettell C, Young G, et al: Delayed and progressive brain injury in closed-head trauma: radiological demonstration. Neurosurgery 32:25-31, 1993
72. Taupin V, Toulmond S, Serrano A, et al: Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion. Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J Neuroimmunol 42:177-185, 1993
73. Tchelingerian JL, Quinonero J, Booss J, et al: Localization of TNFα and IL-1α immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron 10:213-224, 1993
74. Terada LS, Willingham IR, Guidot DM, et al: Tungsten treatment prevents tumor necrosis factor-induced injury of brain endothelial cells. Inflammation 16:13-19, 1992
75. Todd NV, Graham DI: Blood-brain barrier damage in traumatic brain contusions. Acta Neurochir Suppl 51:296-299, 1990
76. Toulmond S, Rothwell NJ: Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res 671:261-266, 1995
77. Unterberg A, Kiening K, Schmiedek P, et al: Long-term observations of intracranial pressure after severe head injury. The phenomenon of secondary rise of intracranial pressure. Neurosurgery 32:17-24, 1993
78. Woodroofe MN, Sarna GS, Wadhwa M, et al: Detection of interleukin-1 and interleukin-6 in adult rat brain, following mechanical injury, by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol 33: 227-236, 1991
79. Wu X, Wittwer AJ, Carr LS, et al: Cytokine-induced neutrophil chemoattractant mediates neutrophil influx in immune complex glomerulonephritis in rat. J Clin Invest 94:337-344, 1994
80. Yamasaki Y, Matsuura N, Shozuhara H, et al: Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 26:676-681, 1995